eNewsroom for: Replikins

http://www.ereleases.com/pr/wp-content/Cimy_User_Extra_Fields/Replikins/index01.jpg

Replikins Company Profile

Replikins, Ltd. develops and markets novel forecasting tools and synthetic vaccines to fight virulent rapidly replicating diseases including bird flu, malaria, and HIV. The company's predictive products and vaccines in development are based upon the company's discovery of Replikins, a new group of peptides related to the rapid replication function in viral and other diseases. The company has designed unique products to predict the emergence of virulent strains of particular diseases (FluForecastâ„¢) and is designing synthetic vaccines specifically tailored to combat a given strain and against shared properties of several strains (Syntopeâ„¢ vaccines). The company is partnering with governments and the private sector in providing predictive tools and vaccines in furtherance of the public health initiative to prevent and combat epidemics.

News from Replikins:

Increased Risk of H1N1 (Swine Flu) Pandemic #3 Found in Replikins Gene FluForecast®

Completely Synthetic Replikins Vaccine H1N1Pan3™ Is Available Now

LONDON, Dec. 31, 2013 /PRNewswire/ – Bioradar UK Ltd. announced today that analysis of 35,529 sequences in two H1N1 Replikins genes, from 1918 to 2013, indicates that the risk of a third H1N1 (Swine Flu) pandemic has inc…

Drop in Gene Replikin Counts of Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) Suggests Decrease in Risk of Pandemic, but Counts Rise Again

Bioradar UK Ltd. Cautions Against Relaxing Public Health Measures Given Four-Month Lag in Available Data, Lessons from SARS
LILLE, France, Oct. 21, 2013 /PRNewswire/ – Bioradar UK Ltd. announced today at the Vaccine Congress Europe in Lille that quantitative real-time Replikins Analysis o…

New Genomic Analysis Shows H5N1 (Bird Flu) Replikin Count Highest Among Five Influenza Strains

Elevated Threat of Pandemic; Candidate Replikins Vaccines to be announced at World Vaccine Congress Europe October 16-17, 2013, Lille France
LONDON, Oct. 9, 2013 /PRNewswire/ — Replikins are specific gene structures quantitatively related to rapid replication and outbreaks of viruses (1).…

Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25

LONDON, April 18, 2013 /PRNewswire/ – Replikins Ltd will reveal details on the availability of two completely synthetic vaccine candidates, both with long-term prevention goals and acute short-term blocking capacity.  One of these vaccines targets H7N9 alone, the other for H7N9 plus the o…

H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic

LONDON, April 9, 2013 /PRNewswire/ — Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died fr…

H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic

LONDON, April 9, 2013 /PRNewswire/ — Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died fr…

Future Course of New Lethal Avian Flu Outbreak in China Can Be Predicted

Will H7N9 Follow Limited Course of SARS or Longer Course of H1N1 Pandemic? Can a Potential Pandemic Be Prevented?
LONDON, April 8, 2013 /PRNewswire/ — Bioradar UK Ltd. and Replikins Ltd. today announced that when the full H7N9 virus genomic sequences from the first lethal and surviving human case…

Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria

Replikins Synthetic Vaccines Against Antibiotic-Resistant Gonococcus, Tuberculosis, Staphylococcus, Streptococcus, Klebsiella KPC, and Cl. Difficile
OTTAWA, Ontario, March 14, 2013 /PRNewswire/ – A group of lethal bacteria are of increasing concern worldwide because they are becom…

Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count

LONDON, Feb. 19, 2013 /PRNewswire/ – Bioradar UK Ltd has found that the virus genomic Replikin® Count in Hand-Foot-Mouth Disease (HFMD) increased fourfold worldwide from 2005 to 2012 (Figure). All HFMD genomes on Pubmed were analyzed for Replikins (References). Increase in the genomic Rep…

New Shared Synthetic Replikin Cancer Vaccines

Conserved Genomic Replikin Peptides were found to be Shared in Histologically Different  Common Lethal Human Cancers
BOSTON, Jan. 22, 2013 /PRNewswire/ — Replikins Ltd. and Brain Research Associates announced today that specific conserved genomic Replikin peptide sequences for the first…

Replikin Count of Influenza H3N2 Replikin Lethality Gene in the U.S. Approaches That of 1968 H3N2 Pandemic

LONDON, Jan. 16, 2013 /PRNewswire/ – Bioradar UK Ltd this week reported that the H3N2 Lethality Gene Counts are approaching those of the highly lethal H3N2 pandemic of 1968 (1)(see Figure).
(Photo: http://photos.prnewswire.com/prnh/20130116/PH43879-INFO )
The severe flu outbreaks…

2012 ‘State Fair’ Swine Flu H3N2 Outbreak in U.S. Was Correctly Predicted by Increase in Genomic Replikin®Count Two Years Earlier

Can New Synthetic Replikin TransFlu Vaccines Prevent 2013-14 Swine Outbreak?
 
Advanced Flu Prediction and New Synthetic Vaccines Offer Government Important New Tools to Prevent Pandemics from Developing
LONDON, Nov. 29, 2012 /PRNewswire/ — Bioradar UK Ltd today concluded that an incr…

Five New Cases of SARS-like Virus Bring Total to Seven, Prompting Calls for Immediate Trials of New Synthetic Replikin™Vaccine SARS2012

BioRadar UK Ltd. Warned on Oct. 5 of Rise in Human SARS Virus Genomic Replikin™Count to Levels that Preceded the 2003 Lethal SARS Outbreak
LONDON, Nov. 27, 2012 /PRNewswire/ — The World Health Organization (WHO) last week reported that four new cases of SARS-like virus have been found in Saudi Ar…

The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC

Highest Ever ReplikinCounts in H5N1 HA and p B1 Genes in 2010 and 2011 Predict Increased Infectivity and Lethality
 
Replikins TransFlu™Vaccine Updated
LONDON, Nov. 6, 2012 /PRNewswire/ – In the lead paper to be presented at the Influenza Congress USA in Washington DC on November 12, 20…

Human SARS Virus Genomic Replikin™ Count Rises to the Level that Preceded the 2003 Lethal SARS Outbreak

SyntheticReplikin™ VaccineSARS 2012 Now Available for Testing
Can the SARS virus return? An analysis of the current virus’s genomic Replikin Count has revealed the Count to be increased significantly above the preceding low ‘resting’ levels 2004-2011. The Count is now in the s…

Discovered Evolution of Genomic Sequences — from Ocean Archaea to Brain Cancer — Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer

New Book Due in September 2012
LONDON, June 19, 2012 — The Foundation for Research on the Nervous System, Replikins Ltd., and Bioradar UK Ltd. today announced that over 100 new synthetic Replikins vaccines for infectious diseases and cancer are now available as a result of the discovery by scienti…

Current H5N1 Flu Outbreak and Location Predicted in 2009

Cambodian Avian Flu Marks Fifth Time an Increase in the Flu Strain’s Replikins Count® Foretold a (Preventable) Viral Outbreak
LONDON, Feb. 10, 2012 — Bioradar UK Ltd. reported today the fifth instance in which the specific strain and specific location of an influenza outbreak were predi…

FAO Warnings Follow Rise in Replikins Count for Both H5N1 and Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested

U.N. Food and Agriculture Organization Warns of ‘Possible Major Resurgence’ of Avian Flu (H5N1) in Asia and a New Vaccine-Evading Strain in Vietnam and China
LONDON, Aug. 31 2011 — The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a…

U.N. Food and Agriculture Organization Warns of ‘Possible Major Resurgence’ of Avian Flu (H5N1) in Asia and a New Vaccine-Evading Strain in Vietnam and China

FAO Warnings Follow Rise in Replikins Count for Both H5N1 and Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested
LONDON, Aug. 31 2011 — The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a matter of global concern (1, 2). Bioradar UK…

Rising Replikin Counts in E. Coli in Germany Since 2005 Preceded Current E. Coli Outbreak

Synthetic Replikins Therapeutics for E. Coli Now Available for Testing
LONDON, June 20, 2011 — Scientists Drs. Samuel and Elenore Bogoch of BioRadar UK Ltd. announced that retrospective studies indicate that an increase in Replikin Counts of the EHEC lethal strains of E. Coli preceded the curre…

New Finding of Rise in H5N1 Virus (Avian Flu) Replikin Count

Replikins Global BioRadar Surveillance System™ Shows Replikin Count in H5N1 at Record High for 2010
BOSTON, Oct. 27, 2010 — BioRadar™ software correctly predicted the 2009 H1N1 (Swine Flu) outbreak a year in advance (http://www.replikins.com, Replikins Press, 2008). The same rise in Rep…

Current Severe Outbreaks of Foot and Mouth Disease Predicted by Replikins’ BioRadar(TM) One Year in Advance (June 2009)

Replikins TransFoot and Mouth Disease (FMD) Vaccine(TM) Now Available; Highest Replikin Count in FMDV in 52 Years Found in 2009
LONDON, July 16, 2010 — BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Cou…

Both H5N1 Bird Flu and H1N1 Swine Flu Replikin Counts(TM) Are Increasing

H5N1 Outbreaks, Predicted One Year Ago by BioRadar(TM), Now Appear in 63 Countries; TransFlu(TM) Vaccine Shown Effective Against H5N1 in Chickens
LONDON, April 9, 2010 — The most recent BioRadarTM (FluForecastTM) analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, k…

Replikins’ BioRadar(TM) Announced by UK Trade and Investment

Flu Pandemic Warning Company Sets Up in UK
LONDON, March 29, 2010 — UK Trade and Investment (http://www.newsroom.uktradeinvest.gov.uk/news.ashx) has announced the formation of BioRadar UK Limited. BioRadar is building on the recent success of Replikins’ genomic analysis of influen…

Biological H1N1 Vaccines: Too Little, Too Late

Lethality of H1N1 Virus Drops to “Non-Epidemic Resting Levels” in Current Cycle – Virus’ Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessati…

New Non-Biological Synthetic Replikins(TM) Vaccines Shown to Be Effective and Fast; WorldVaccines(TM), Ltd Formed for Testing and Distribution

Old Biological Vaccines for Emergent Diseases — Too Little, Too Late
BOSTON, Oct. 19, 2009 — There is increasing evidence that, with best intent, current biological technology cannot supply the world’s six billion humans, and animal populations, with vaccines against emerging d…

Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data

Boston Biotech Firm Reports First Rise in 76 Years of Replikin Count* of H1N1 Lethality Gene
BOSTON, June 10, 2009 — An analysis of the latest peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of H1N1 is increasing in its capacity for lethality. The new seq…

First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

LONDON, May 4, 2009 — A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandem…

Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 ‘Swine Flu’ Virus Outbreak

BOSTON, April 27, 2009 — Replikins Ltd. published a FluForecast(R) warning in April 7th, 2008, a year before the recent Mexico and California H1N1 cases. The company was able to state the likelihood of H1N1 outbreaks based on its patented Replikin Count(TM) genomics technology, which examines s…

Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data

BOSTON, March 20, 2009 — Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Replikin…

A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks

BOSTON, Nov. 12, 2008 — WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is “suboptimal” — often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predi…

Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes

BOSTON, May 19, 2008 — Replikins Ltd. has found that very high concentrations of its replikin genetic sequences are found in the trypanosomes that are the infectious agents in malaria. The levels found by the company are in fact the highest replikin concentrations observed to date in any infectio…

Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases

BOSTON, May 2, 2008 — Replikins Ltd. has found that the replikin concentration of West Nile Virus increased annually through two distinct cycles as the virus expanded in the U.S.: the first from 2000 to 2003, and the second from 2004 to 2007 (p less than 0.001). Increases in the annual number of human…

H1N1 Influenza Virus With Highest Replikin Count(TM) Since the 1918 Pandemic Identified in the U.S. and Austria

BOSTON, April 7, 2008 — Replikins Ltd. has found that the Replikin Count(TM) of the H1N1 strain of influenza virus has recently increased to 7.6 (plus/minus 1.4), its highest level since the 1918 H1N1 pandemic (p value less than 0.001). A rising Replikin Count of a particular influenza strain, ind…

Replikins Oral Vaccine Synthesized in 7 Days Protects 91% of Shrimp Against a Lethal Virus

BOSTON, March 11, 2008 — Replikins, Ltd. has announced development of a chemically synthesized vaccine specific to a Taura Syndrome virus structure based on its patented Replikins(TM) technology. When the vaccine was administered orally to shrimp, 91% survived a challenge by the lethal Taura…

FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over

BOSTON, Feb. 11, 2008 — Replikins Ltd. announced that the quantitative analysis of Replikin Count(TM) in the virus gene structure predicts that the current H5N1 cycle is over. Sporadic outbreaks may continue, but the rapid epidemic spread and high mortality characteristics are expected to sub…

Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated

BOSTON, Dec. 11, 2007 — Replikins Ltd. today announced its latest findings regarding the virus replikin count in human H5N1 influenza virus. The company’s software-driven analysis has found that the prevalence of these sequences has remained high in Indonesia; in addition, higher coun…

AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers

BOSTON, Dec. 6, 2007 — A gene related to rapid replication and lethality has been found to be present in, and to contain some identical protein sequences in, tobacco mosaic virus and non-small cell lung cancer. The early detection diagnostic test for cancer, the AMAS(R) test, appears to measure th…

Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value

BOSTON, AUG. 3, 2007 — Replikins LLC has discovered a new group of virus structural peptides within virus proteins, called replikins, which provide virus-specific advance quantitative warnings of rapid replication and the risk of epidemics. Replikins LLC has developed software called Repli…

Indonesia Reports Experiencing Human H5N1 Mortality Increase, as Predicted Last Year by Replikins’ FluForecast(R) Quantitative Virus Analysis

BOSTON, June 8, 2007 — The results published in 2006 by Replikins, Ltd. showed that 2005-2006 FluForecast(R) virus data indicated clearly that 1) the mortality rate of human H5N1 was increasing markedly, and that 2) the first country in which this would be clinically realized would be Indonesia.…

FluForecast(R) Trial in 2006 Predicted High Human H5N1 Mortality in Indonesia

BOSTON, May 9, 2007 — When H5N1 was thought to be quiescent in 2006, in a prospective open trial, FluForecast(R), a software program which measures virus gene proteins, predicted high human mortality H5N1 outbreaks to come2. In addition, FluForecast technology predicted that the leading count…